Merit Medical Launches The FDA Cleared Micro ACE Advanced Micro-Access System
Portfolio Pulse from Benzinga Newsdesk
Merit Medical Systems, Inc. (NASDAQ:MMSI) announced the commercial release of its FDA-cleared Micro ACE Advanced Micro-Access System, a part of its Merit Vascular portfolio. The system is designed for micro-access in various vascular anatomies, offering improved stiffness, resistance to kink and compression, and visibility under fluoroscopy compared to competitors. Merit Medical also plans to file for CE mark designation in Europe and is pursuing patents for Micro ACE technology both in the US and internationally.
March 19, 2024 | 1:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical's launch of the FDA-cleared Micro ACE system represents a significant advancement in vascular access technology, potentially enhancing the company's product portfolio and market position.
The introduction of the Micro ACE Advanced Micro-Access System by Merit Medical is likely to have a positive short-term impact on MMSI's stock price. This is due to the product's innovative features that surpass those of competitors, indicating potential for increased market share and revenue. The pursuit of CE mark designation and international patents further suggests a strategic move to expand global market presence, enhancing investor confidence in the company's growth trajectory.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100